Steve Mertens is Chief Technology Officer of NEUROONE MEDICAL TECHNOLOGIES Corp. Currently has a direct ownership of 173,085 shares of NMTC, which is worth approximately $107,312. The most recent transaction as insider was on Feb 03, 2022, when has been sold 41,750 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 173K
0.95% 3M change
107.47% 12M change
Total Value Held $107,312

Steve Mertens Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 03 2022
BUY
Grant, award, or other acquisition
-
41,750 Added 50.0%
41,750 Common Stock
SM

Steve Mertens

Chief Technology Officer
Eden Prairie, MN

Track Institutional and Insider Activities on NMTC

Follow NEUROONE MEDICAL TECHNOLOGIES Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NMTC shares.

Notify only if

Insider Trading

Get notified when an Neuroone Medical Technologies Corp insider buys or sells NMTC shares.

Notify only if

News

Receive news related to NEUROONE MEDICAL TECHNOLOGIES Corp

Track Activities on NMTC